Endocrine System: Histology and Disorders

Cellular Communication and Glandular Organization

• Mechanisms of Intercellular Communication:
  • Endocrine Signaling: Hormones are secreted directly into the bloodstream to act on distant target cells bearing specific receptors.
  • Paracrine Signaling: "Local hormones" diffuse through interstitial fluid to act on neighboring cells (e.g., growth factors).
  • Neuronal Signaling: Neurotransmitters are released across a synaptic cleft.
  • Contact-Dependent Signaling: Direct signaling between cells via membrane-bound signal molecules or gap junctions (connexons) facilitating direct cytoplasmic exchange of ions and small molecules.
  • Neuroendocrine Cells: Hybrid cells that receive neural input and fire action potentials, but release hormones directly into circulation (e.g., hypothalamic neurosecretory cells, adrenal chromaffin cells, pinealocytes).

• Glandular Differences:
  • Exocrine Glands: Secrete products via ducts onto epithelial surfaces (e.g., skin, digestive lumen) exerting extracellular effects.
  • Endocrine Glands: Ductless structures with a high density of fenestrated capillaries; release internal secretions into the bloodstream to exert intracellular metabolic effects.
  • Mixed Glands: Exhibit both exocrine and endocrine functions (e.g., liver, pancreas).

Hormone Chemistry, Synthesis, and Transport

• Chemical Classes:

  • Steroids: Synthesized from cholesterol; characteristic four-ring backbone; hydrophobic (e.g., testosterone, estradiol, progesterone, cortisol, aldosterone).
  • Monoamines: Synthesized from aromatic amino acids via decarboxylase enzymes requiring vitamin $B_6$ (e.g., epinephrine, norepinephrine, dopamine, melatonin, thyroid hormone).
  • Peptides: Oligopeptides to large polypeptides (3 to 200+ amino acids); synthesized via transcription, translation on the rough endoplasmic reticulum, signal recognition particle (SRP) docking, Golgi processing, and secretory vesicle exocytosis (e.g., insulin, glucagon, oxytocin, hypothalamic releasing/inhibiting hormones).

• Thyroid Hormone Synthesis:

  • Follicular cells absorb iodide ($I^-$) and secrete thyroglobulin into the follicle colloid.
  • Iodide is oxidized to iodine and added to tyrosine residues on thyroglobulin.
  • Tyrosines link to form tetraiodothyronine ($T_4$) and triiodothyronine ($T_3$); upon stimulation, lysosomes hydrolyze stored thyroglobulin to release $90\%$ $T_4$ and $10\%$ active $T_3$.

• Circulatory Transport:

  • Hydrophilic Hormones: Peptides and most monoamines circulate as free (unbound) molecules ($100\%$ free).
  • Hydrophobic Hormones: Steroids and thyroid hormones circulate predominantly bound ($>99\%$) to plasma transport proteins (albumin, globulins), which protects them from enzymatic degradation and prolongs half-life.

Mechanisms of Action and Signal Kinetics

• Intracellular & Nuclear Receptors (Gene Activation):

  • Hydrophobic hormones (steroids, $T_3$) penetrate the cell membrane.
  • Bind cytosolic or nuclear receptors, dimerize (e.g., $T_3$ with RXR and THR at thyroid hormone response elements [TRE]), and alter gene transcription.
  • Characterized by a noticeable time lag before physiological response.

• Second-Messenger Systems (Cell-Surface Receptors):

  • Hydrophilic peptides and catecholamines bind cell-surface G-protein coupled receptors (GPCRs).
  • Adenylyl Cyclase Pathway: GPCR activation engages the $G_s$ alpha subunit $\rightarrow$ adenylyl cyclase catalyzes ATP $\rightarrow$ cyclic AMP (cAMP) $\rightarrow$ protein kinase A (PKA) activation $\rightarrow$ phosphorylation of downstream target enzymes.
  • Phospholipase C (PLC) Pathway: GPCR activation activates PLC $\rightarrow$ cleaves phosphatidylinositol 4,5-bisphosphate ($\text{PIP}_2$) into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate ($\text{IP}_3$).
  • $\text{IP}_3$ triggers $Ca^{2+}$ release from the endoplasmic/sarcoplasmic reticulum into the cytosol.
  • Cytosolic $Ca^{2+}$ binds calmodulin (a dumbbell protein with four $Ca^{2+}$-binding sites) to activate CaM-kinases or myosin light-chain kinase (MLCK).
  • DAG recruits and activates protein kinase C (PKC) to phosphorylate target cellular proteins.

• Signal Dynamics and Clearance:
  • Signal Amplification: A single hormone-receptor binding event triggers a reaction cascade generating up to $10^8$ product molecules (e.g., glucagon signaling leading to glucose-1-phosphate).
  • Modulation: Target cells up-regulate receptors (increase sensitivity) under low hormone concentrations or down-regulate receptors (decrease sensitivity) during prolonged hormone exposure.
  • Metabolic Clearance Rate (MCR): Clearances occur primarily in the liver and kidneys; systemic clearance is calculated as:     $Cl_S = Cl_R + Cl_H + Cl_B + Cl_{\text{other}}$$Cl_S = \frac{\text{Dose}}{\text{AUC}}$

Hypothalamic and Pituitary Control

• Stimulus Categories for Hormone Secretion:
  • Neural Stimuli: Direct nerve fiber activation (e.g., sympathetic preganglionic fibers stimulating adrenal chromaffin cells; suckling/cervical stretch stimulating hypothalamic oxytocin release).
  • Hormonal Stimuli: Trophic hormones triggering downstream hormonal output (e.g., TRH $\rightarrow$ TSH $\rightarrow$ TH).
  • Humoral Stimuli: Direct sensing of blood concentrations (e.g., low blood $Ca^{2+}$ stimulating PTH; high glucose stimulating insulin; elevated plasma osmolarity stimulating ADH).

• Hypothalamo-Hypophysial Portal System:

  • Hypothalamic neurosecretory cells secrete releasing and inhibiting factors into the primary capillaries supplied by the superior hypophyseal artery.
  • Blood flows down portal venules into secondary capillaries within the anterior pituitary to regulate epithelial endocrine cells.

• Hypothalamic Regulators and Anterior Pituitary Hormones:

  • Thyrotropin-releasing hormone (TRH): Promotes TSH and PRL secretion.
  • Corticotropin-releasing hormone (CRH): Promotes ACTH secretion.
  • Gonadotropin-releasing hormone (GnRH): Promotes FSH and LH secretion.
  • Growth hormone-releasing hormone (GHRH): Promotes GH secretion.
  • Prolactin-inhibiting hormone (PIH / Dopamine): Inhibits PRL secretion.
  • Somatostatin: Inhibits GH and TSH secretion.

• Anterior Pituitary Histology & Secretory Cells:

  • Acidophils: Somatotropes (GH) and Lactotropes (PRL).
  • Basophils: Thyrotropes (TSH), Corticotropes (ACTH), Gonadotropes (FSH and LH).
  • Chromophobes: Non-staining, resting, or degranulated cells.

• Posterior Pituitary (Neurohypophysis):
  • Nervous tissue consisting of unmyelinated axons and glial cells (pituicytes).
  • Stores and secretes hormones synthesized in hypothalamic nuclei:
  • Paraventricular Nucleus: Produces oxytocin (triggers uterine contraction and myoepithelial contraction for milk ejection).
  • Supraoptic Nucleus: Produces Antidiuretic Hormone (ADH / Vasopressin).
  • ADH Action: Binds basolateral GPCRs on kidney distal convoluted tubules and collecting ducts $\rightarrow$ stimulates adenylyl cyclase/PKA $\rightarrow$ dephosphorylation of Ser261 and phosphorylation of Ser256/Ser269 $\rightarrow$ exocytic apical insertion of Aquaporin-2 (AQP2) water channels to reabsorb water.

Peripheral Endocrine Gland Function

• Pineal Gland:

  • Contains pinealocytes and astrocytes; integrates photoperiod signals via retinal pathways and superior cervical sympathetic ganglia to synthesize melatonin from serotonin at night.

• Thymus:

  • Located in the anterior mediastinum; cortex contains a blood-thymus barrier.
  • Secretes thymopoietin, thymosin, and thymulin to drive T cell maturation and immune competence.

• Parathyroid Glands:

  • Chief Cells: Express calcium-sensing G-protein receptors; secrete Parathyroid Hormone (PTH) when blood $Ca^{2+}$ drops.
  • PTH Function: Stimulates osteoclast bone resorption, promotes renal $Ca^{2+}$ reabsorption, enhances renal phosphate excretion, and activates renal 1-alpha-hydroxylase to produce active vitamin D (calcitriol) for intestinal $Ca^{2+}$ uptake.
  • Oxyphil Cells: Distinct large cells of unknown function.

• Adrenal Gland:

  • Adrenal Cortex:
  • Zona Glomerulosa (outer, rounded clusters): Secretes mineralocorticoids (aldosterone).
  • Zona Fasciculata (thick middle layer, parallel cords/spongiocytes): Secretes glucocorticoids (cortisol).
  • Zona Reticularis (inner branching network): Secretes androgens (DHEA) and small amounts of glucocorticoids.
  • Adrenal Medulla: Chromaffin cells (modified postganglionic sympathetic neurons) secrete catecholamines (epinephrine and norepinephrine) under sympathetic command.

• Renin-Angiotensin-Aldosterone System (RAAS):

  • Activated by a drop in renal perfusion pressure (renal baroreceptors), decreased $Cl^-$ delivery to the macula densa, or sympathetic $\beta_1$ stimulation.
  • Juxtaglomerular granular cells release renin, which converts hepatic angiotensinogen to angiotensin I.
  • Angiotensin-converting enzyme (ACE) in pulmonary capillaries converts angiotensin I to angiotensin II.
  • Angiotensin II stimulates arteriolar vasoconstriction and triggers aldosterone release from the zona glomerulosa.
  • Aldosterone acts on distal tubule/collecting duct principal cells to upregulate apical $Na^+$ channels (ENaC) and basolateral $Na^+/K^+$ ATPases, promoting $Na^+$ and water reabsorption while enhancing $K^+$ excretion.

• Pancreatic Islets of Langerhans:

  • Alpha ($\alpha$) Cells ($\approx 20\%$): Secrete glucagon in response to hypoglycemia ($<100\,\text{mg/dL}$), promoting hepatic glycogenolysis and gluconeogenesis.
  • Beta ($\beta$) Cells ($\approx 70\%$): Secrete insulin (promotes glucose uptake in skeletal muscle and adipose tissue via GLUT4, drives glycogen synthesis) and amylin (slows gastric emptying and induces satiety).
  • Delta ($\delta$) Cells ($<5\%$): Secrete somatostatin, a paracrine inhibitor of both insulin and glucagon secretion.
  • Acinar Cells: Exocrine function, secreting digestive enzymes.

• Growth Hormone (GH) and Insulin-Like Growth Factors:

  • GH has a short half-life ($6\text{ to }20\,\text{min}$) and directly promotes lipolysis, decreases peripheral glucose uptake, and increases hepatic gluconeogenesis.
  • Stimulates the liver to synthesize IGF-1 and IGF-2, which mediate long-term anabolic actions (collagen deposition, osteogenesis, skeletal muscle protein synthesis).
  • Regulated via negative feedback where IGF-1 suppresses GHRH and stimulates somatostatin; gastric ghrelin stimulates GH secretion.

Endocrine Disorders and Clinical Pathologies

• Growth Hormone Pathologies:

  • Gigantism: Hypersecretion of GH in childhood prior to epiphyseal plate closure.
  • Acromegaly: Hypersecretion of GH in adulthood after epiphyseal plate fusion; causes bone thickening, soft tissue hypertrophy, enlarged craniofacial bones, insulin resistance, and secondary diabetes mellitus (as observed in historical patients such as Mary Ann Bevan).
  • Pituitary Dwarfism: Hyposecretion of GH during childhood.
  • GH Deficiency in Adults: Accelerates atherosclerosis, elevates LDL, central adiposity, endothelial dysfunction, and vascular resistance.

• Thyroid and Parathyroid Pathologies:

  • Hypothyroidism: Decreased basal metabolic rate, cold intolerance, lethargy, bradycardia, weight gain, constipation.
  • Hyperthyroidism: Accelerated metabolism, weight loss, heat intolerance, tachycardia, arrhythmias, anxiety, tremors.
  • Endemic Goiter: Dietary iodine deficiency impairs TH synthesis; absence of negative feedback results in excessive TSH secretion, prompting follicular cells to continuously produce unusable thyroglobulin and distend the colloid.
  • Hypoparathyroidism: Accidental excision during thyroidectomy or PTH resistance; causes hypocalcemia, increased bone density, and fatal hypocalcemic tetany (laryngeal spasm) within days.
  • Hyperparathyroidism: Usually caused by a parathyroid adenoma; results in severe hypercalcemia, soft and demineralized bones, and recurrent calcium nephrolithiasis (kidney stones).

• Glucose and Fluid Regulation Disorders:

  • Diabetes Mellitus Type 1: Autoimmune destruction of pancreatic $\beta$ cells, causing absolute insulin deficiency, wasting, and severe ketoacidosis (demonstrated by early insulin therapy in patients like Elizabeth Hughes).
  • Diabetes Mellitus Type 2: Peripheral tissue insulin resistance coupled with relative secretory dysfunction; associated with significant morbidity across older demographic cohorts.
  • Diabetes Insipidus: Hyposecretion of ADH (central) or renal insensitivity to ADH (nephrogenic), resulting in polyuria, polydipsia, and hypoosmotic urine.

• Adrenal and Steroid Pathologies:

  • Cushing's Syndrome: Hypersecretion of glucocorticoids (cortisol); characterized by muscle proteolysis, central adiposity, hyperglycemia, osteoclast activation, and insulin resistance.
  • Adrenogenital Syndrome (AGS): Prenatal hypersecretion of adrenal androgens; masculinizes genetic females (XX), causing clitoromegaly and labial fusion resembling a scrotum (ambiguous genitalia).
  • Androgen Insensitivity Syndrome (AIS): Karyotype 46,XY with functional abdominal testes and normal testosterone levels, but lacking functional androgen receptors; external development follows female phenotypic lines, without a uterus or menses.
  • Polycystic Ovary Syndrome (PCOS): Anovulation, fluid-filled ovarian cysts, and androgen hypersecretion, exacerbated by hyperinsulinemia and insulin resistance.
  • Multiple Endocrine Neoplasia (MEN):
  • MEN Type I: Neoplasia affecting the parathyroid glands, pancreas, and pituitary gland.
  • MEN Type II: Medullary thyroid carcinoma, parathyroid hyperplasia, and pheochromocytoma of the adrenal medulla ($50\%$ of cases), commonly accompanied by mucosal neuromas on the tongue and lips.